The porphyrin-fullerene nanoparticles to promote the ATP overproduction in myocardium: 25Mg2+-magnetic isotope effect

European Journal of Medicinal Chemistry

Volumn 44, Issue 4, 2009, Pages 1554-1569

  Rezayat, S M ^a   Boushehri, S V S ^a   Salmanian, B ^a   Omidvari, A H ^a   Tarighat, S ^a   Esmaeili, S ^a   Sarkar, S ^b   Amirshahi, N ^c   Alyautdin, R N ^c   Orlova, M A ^d   Trushkov, I V ^d   Buchachenko, A L ^e   Liu, K C ^e   Kuznetsov, D A ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

^e SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

Author keywords

25Mg2+ magnetic isotope effect; ATP overproduction; Myocardium hypoxia; Porphyrin fullerenes

Indexed keywords

1 METHYLNICOTINAMIDE; ADENOSINE TRIPHOSPHATE; DOXORUBICIN; FERRITIN; HEMOGLOBIN; ISOTOPE; MAGNESIUM 25; MYOGLOBIN; NANOPARTICLE; PORPHYLLEREN MC16; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL ENERGY; CELL METABOLISM; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG UPTAKE; ENZYME SYNTHESIS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANOXIA; DRUG DISCOVERY; FULLERENES; HEART; HYDROGEN-ION CONCENTRATION; ISOTOPES; MAGNESIUM; MAGNETICS; MALE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MYOCARDIUM; NANOPARTICLES; NEUTRON DIFFRACTION; OXYGEN; PORPHYRINS; RATS; RATS, WISTAR; SCATTERING, SMALL ANGLE;

EID: 61349102417     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.07.030     Document Type: Article

References (56)

1. S. Sarkar, S.M. Rezayat, A.L. Buchachenko, D.A. Kuznetsov, M.A. Orlova, M.A. Yurovskaya, I.V. Trushkov, New water soluble porphylleren compounds, European Union Patent No. 07009882.7/EP07009882, Reg.: Munich, Germany, 2007.
2. S. Sarkar, S.M. Rezayat, A.L. Buchachenko, D.A. Kuznetsov, M.A. Orlova, M.A. Yurovskaya, I.V. Trushkov, Use of a magnesium isotope for treating hypoxia and a medicament comprising the same, European Union Patent No. 07009881.9/EP07009881, Reg.: Munich, Germany, 2007.
3. Wallace K.B., and Starkov A.A. Mitochondrial targets of drug toxicity. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 353-388
4. Souid A.K., Tacka K.A., Galvan K.A., and Penefsky H.S. Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem. Pharmacol. 66 (2003) 977-987
5. Wallace K.B. Doxorubicin-induced cardiac mitochondriopathy. Pharmacol. Toxicol. 93 (2003) 105-115
6. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P. Molecular Biology of the Cell (2002), Garland Science Publ., NY
7. Waugh T., and Telashima H. Mitochondria (2004), Research Triangle Publ., Raleigh, Durham, NC
8. 26Mg isotope effect in mitochondrial ADP phosphorylation. Cell Biochem. Biophys. 43 (2005) 243-252
9. Buchachenko A.L., Kuznetsov D.A., Arkhangelsky S.E., Orlova M.A., and Markarian A.A. Spin biochemistry: intramitochondrial nucleotide phosphorylation is a magnesium nuclear spin controlled process. Mitochondrion 5 (2005) 67-70
10. Buchachenko A.L., Kuznetsov D.A., Orlova M.A., and Markarian A.A. Magnetic isotope effect of magnesium in phosphoglycerate kinase phosphorylation. Proc. Natl. Acad. Sci. USA 102 (2005) 10793-10797
11. Buchachenko A.L., Kuznetsov D.A., Breslavskaya N.N., and Orlova M.A. Magnesium isotope effects in enzymatic phosphorylation. J. Phys. Chem., Ser. B 112 (2008) 2548-2556
12. Kano K. Molecular complexes of water-soluble porphyrins. J. Porphyrin Phthalocyanines 8 (2004) 148-155
13. Hudson R., Mallroy C., Darnell S., and Smith K.M. Porphyrin conjugates in photoimmunotherapy. Br. J. Cancer 93 (2006) 1442-1450
14. Pawar R., Avramoff A., and Domb A.J. Nanoparticles for crossing biological membranes. In: Kumar C.S.S.R. (Ed). Biological and Pharmacological Nanomaterials (2007), Wiley-VCH, Weinheim-Baton Rouge, LA 349-393
15. Tyler D.D., and Gonze J. The preparation of heart mitochondria from laboratory animals. Methods Enzymol. 10 (1967) 75-122
16. Gergely M., and Lakatos I. Molecular and Cellular Cardiology (1999), Alba Regia, Budapest, Szeged
17. Mahatoo R. Biological membranes and barriers. In: Telashima I., and Waugh J.A. (Eds). Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids (2005), CRC Press, NY 241-260
18. Bradford M.M. An improved colorimetric technique for protein measurement. Anal. Biochem. 72 (1976) 348-354
19. 59Fe-labeled organelle supplemented with an electron microscopic track study. Bull. Exp. Biol. Med. 58 (1997) 668-674
20. Piotrovsky L.B., and Kiselyov O.I. Fullerenes in Biology: On the Way Towards Nanomedicine (2006), Rostok Publ., St. Petersburg (in Russian)
21. The Nanofinder-S16E: Laser Confocal Microscopy-Raman Spectroscopy Unit. Technical Manual (2006), Nanofinder Co. Publ., Minsk, Grodno (Byelorussia)
22. Kuznetsov D.A., Govorkov A.V., Zavijalov N.V., Silbileva T.M., Richter V., and Drawczek J.A. Fast estimation of ATP/ADP ratio as a special step in pharmacological and toxicological studies using the cell-free translation system. J. Biochem. Biophys. Methods 13 (1986) 53-56
23. Lo L.W., Koch C.J., and Wilson D.F. Calibration of oxygen-dependent quenching of the phosphorescence of Pd-meso-tetra-(4-carboxyphenyl)porphine: a phosphor with general application for measuring oxygen concentration in biological systems. Anal. Biochem. 236 (1996) 153-160
24. Vinogradov S.A., and Wilson D.F. Metallotetrabenzoporphyrins. New phosphorescent probes for oxygen measurements. J. Chem. Soc., Perkin Trans. 2 (1995) 103-111
25. Radioimmunoassays and Related Analytical Techniques. Technical manual by Bio-Rad (2006), Bio-Rad Press, Durham, St. Petersburg
26. Bielka H., Lottmeyer K., Roetzsch K., Schumm O., Wietzel D., and Rauch M. The human blood cells biomass in a drug metabolites uptake screening. Clin. Exp. Pathol. 16 (1996) 444-458
27. Benet L.Z., and Galeazzi R.L. Determination of the steady-state volume drug distribution. J. Pharmacol. Sci. 68 (1979) 1071-1074
28. Morgan D.J., and Smallwood R.A. Clinical significance of pharmacokinetic models of hepatic elimination. Clin. Pharmacokinet. 18 (1990) 61-76
29. Birkett D.J. Pharmacokinetics Made Easy (1998), McGraw Hill Publ., Sydney, Melbourne
30. 60-fullerene molecule toxic?. Full. Nanotub. Carb. Nanostruct. 13 (2005) 363-376
31. 60 dyads with high ability to form photo-induced charge-separated state as novel sensitizers for photodynamic therapy. Photochem. Photobiol. 81 (2005) 891-897
32. Lin Y.L., Lei H.Y., Chou C.K., and Liu H.S. Light-independent inactivation of dengue-2 virus by carboxyfullerene C3 isomer. Virology 275 (2000) 258-262
33. Mashino T., Okuda K., Hirota T., Hirobe M., Nagano T., and Mochizuki M. Inhibition of E. coli grow by fullerene derivatives and inhibition mechanism. Bioorg. Med. Chem. Lett. 9 (1999) 2959-2962
34. Suarez M., Verdecia Y., Illescas B., Martines-Alvarez R., Alvarez A., Ochoa E., Seoane C., Kayali N., and Martin N. Synthesis and study of novel fulleropyrrolidines bearing biologically active 1,4-dihydropyridines. Tetrahedron 59 (2003) 9179-9186
35. Pantarotto D., Tagmatarchis N., Bianco A., and Prato M. Synthesis and biological properties of fullerene-containing amino acids and peptides. Minirev. Med. Chem. 4 (2004) 805-814
36. Tabata Y., and Ikada Y. Biological functions of fullerenes. Pure Appl. Chem. 71 (1999) 2047-2053
37. Baierl T., and Siedel A. The in vitro effects of fullerene black on immunofunctions of macrophages. Fullerene Sci. Technol. 4 (1996) 1073-1085
38. M. Mellul, Cosmetic make-up composition containing a fullerene or mixture of fullerenes, US Patent No. 561202, 1997.
39. J.E. Leone, P.V. Narayanan, Catheter system having fullerenes and method, US Patent No. 6468244, 2002.
40. Schmitt L., Ludwig M., Gaub H.E., and Tampe R. A metal-chelating microscopy tip as a new toolbox for single-molecule experiments by atomic force microscopy. Biophys. J. 78 (2000) 3275-3285
41. Fotiadis D., Scheuring S., Müller S.A., Engel A., and Müller D.J. Imaging and manipulation of biological structures with the AFM. Micron 33 (2002) 385-397
42. Kumar M.N.V.R. Nano and microparticles as controlled drug delivery devices. Journal of Pharmacy and Pharmaceutical Science 3 2 (2000) 234-258
43. Pankhurst Q.A., Connolly J., Jones S.K., and Dobson J. Application of magnetic nanoparticles in biomedicine. J. Appl. Phys. Series D. 36 (2003) R167-R181
44. Kubik T., Bogunia K., and Sugisaka M. Nanotechnology on duty in medicinal applications. Curr. Pharm. Biotechnol. 6 (2005) 17-33
45. Gad S.C. Drug Safety Evaluation (2002), John Wiley & Sons, Inc., New York, Boston, Toronto
46. Hoft F.H., Hohlfeld I.B., and Salata O.V. Nanoparticles: known and unknown risks. J. Nanobiotechnol. 2 (2004) 12-24
47. Hong R., Fisher N.O., Verma A., Goodman C.M., Emrick T., and Rotello V.M. Control of protein structure and function through surface recognition by scaffolds. J. Am. Chem. Soc. 126 (2004) 739-743
48. Rajagopalan P., Wudl F., Schinazi R.F., and Boudiont F.D. Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob. Agents Chemother. 40 (1996) 2262-2265
49. Emerich D.F., and Thanos C.G. Nanotechnology and medicine. Exp. Opin. Biol. Ther. 3 (2003) 655-667
50. Salata O.V. Application of nanoparticles in biology and medicine. J. Nanotechnol. 2 (2004) 261-268
51. Moghimi S.M., Hunter A.C., and Murray J.C. Nanomedicine: current status and future prospects. FASEB J. 19 (2005) 311-330
52. Magrez A., Kasas S.V., Salicio V., Pasquier N., Seo J.W., Celio M., Catsicas S., Schwaller B., and Forro L. Cellular toxicity of carbon-based nanomaterials. Nano Lett. 6 (2006) 1261-1268
53. Logham N., Pratt S.M., Crowdell J.A., Rodriguez A., Drumm T., and Wladcziewski P. Aromatic and Heterocyclic Derivatives of Fullerene-C60 in the Biological Compartments Distribution Study. Pharmacokinetics and Pharmacodynamics Regularities. In: Rattenau W., and Gorowitz H. (Eds). Perspectives in Xenobiochemistry (2008), Jagellon Academia Press, Krakow, Poznan 467-481
54. Foley S., Crowley C., Smaihi M., Bonfis C., Erlanger B.F., Seta P., and Larroque C. Cellular localization of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun. 294 (2002) 116-119
55. Amirshahi N., Alyautdin R.N., Rezayat S.M., Sarkar S., Orlova M.A., Orlov A.P., Poloznikov A.A., and Kuznetsov D.A. The fullerene-interfaced porphyrin ligand in affinity chromatography of membrane proteins. Chromatographia 68 (2008) 437-441
56. Amirshahi N., Alyautdin R.N., Orlov A.P., Poloznikov A.A., and Kuznetsov D.A. Porphyrin binding membrane proteins in rat myocardium. Russ. J. Phys. Chem. 87 (2008) 623-628